CPI-0610 carboxylic acid

CAS No. 1380089-81-5

CPI-0610 carboxylic acid( —— )

Catalog No. M32861 CAS No. 1380089-81-5

CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 800 Get Quote
5MG 1121 Get Quote
10MG 1501 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CPI-0610 carboxylic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein.
  • Description
    CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein. CPI-0610 carboxylic acid may have anticancer and anticancer activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Epigenetic Reader Domain | Ligands for Target Protein for PROTAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1380089-81-5
  • Formula Weight
    366.8
  • Molecular Formula
    C20H15ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1C=2C=3C(C(=N[C@@H](CC(O)=O)C2ON1)C4=CC=C(Cl)C=C4)=CC=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • OXF BD 02

    OXF BD 02 is a potent and selective BRD4(1) inhibitor (IC50: 382 nM) with anticancer and anti-inflammatory activity.

  • BET bromodomain inhi...

    It is a BET bromodomain inhibitor.

  • IRAK4-IN-1

    IRAK4-IN-1 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor with an IC50 of 7 nM.